Vmn1r173 Inhibitors
Vmn1r173, classified as a vomeronasal receptor, serves as a crucial molecular player in the intricate world of chemosensory perception. Functionally, these receptors play a pivotal role in detecting and transducing chemical cues, particularly pheromones, which convey essential information about the environment and social interactions. Vmn1r173, being a member of the vomeronasal receptor family, is likely involved in recognizing specific chemical ligands that signal various physiological and behavioral responses in a species-specific manner. The activation of Vmn1r173 involves a sophisticated interplay of signaling pathways typically associated with G protein-coupled receptors (GPCRs). Upon ligand binding, Vmn1r173 likely triggers downstream cascades that involve G proteins and various kinases, culminating in cellular responses. The exact pathways are not explicitly defined, but GPCRs often engage in signaling networks such as MAPK/ERK, PI3K/Akt, and cAMP-mediated pathways. These intricate mechanisms allow Vmn1r173 to relay external chemical signals into intracellular events, contributing to the sensory perception and behavioral responses characteristic of vomeronasal receptors.
Inhibition of Vmn1r173 involves targeting key components within its signaling pathways, as outlined in the previous table. These inhibitory mechanisms act at different points in the cascade, disrupting the normal signaling flow initiated by Vmn1r173 activation. Pertussis Toxin, for example, interferes with G protein coupling, while inhibitors like H89 and LY294002 target kinases downstream of the receptor. U0126 and SB203580 disrupt the MAPK/ERK and p38 MAPK pathways, respectively. Collectively, these inhibitors aim to impede the intricate signaling network initiated by Vmn1r173, preventing or diminishing the downstream cellular responses normally triggered by the receptor's activation. Understanding these inhibitory mechanisms provides insights into the potential regulation and modulation of Vmn1r173-mediated chemosensory signaling, contributing to the broader comprehension of the molecular processes governing chemosensory perception in mammals.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis Toxin inhibits G protein activation, affecting GPCR signaling. In the context of Vmn1r173, which is likely coupled to a G protein, Pertussis Toxin could indirectly inhibit downstream signaling pathways involved in its activation, reducing cellular responses. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK, a key kinase in the MAPK/ERK pathway. As GPCRs often activate this pathway, U0126 could interfere with the signaling cascade initiated by Vmn1r173, inhibiting the downstream effects and reducing the receptor's activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, may impede the activation of p38 MAPK downstream of Vmn1r173. As GPCRs can influence MAPK pathways, inhibiting p38 MAPK with SB203580 could attenuate the cellular responses mediated by Vmn1r173. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, impacting downstream signaling cascades. In the context of Vmn1r173, which may activate PI3K-related pathways, Wortmannin could interfere with the signaling initiated by the receptor, potentially inhibiting its cellular responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, may interfere with the PI3K/Akt signaling cascade activated by Vmn1r173. This could lead to a reduction in downstream signaling events and potentially inhibit the cellular responses triggered by the receptor. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
AG1478, an EGFR inhibitor, might impact pathways downstream of Vmn1r173. If Vmn1r173 signals through the EGFR pathway, AG1478 could inhibit the receptor's activation and downstream cellular responses. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK, a downstream effector of GPCR-mediated signaling. If Vmn1r173 signals through a Gα12/13 pathway, Y-27632 could inhibit the activation of ROCK, potentially attenuating the cellular responses mediated by Vmn1r173. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I, a PKC inhibitor, may affect pathways downstream of Vmn1r173. If Vmn1r173 activates PKC-related signaling cascades, inhibiting PKC with Bisindolylmaleimide I could decrease the cellular responses mediated by the receptor. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2, a Src kinase inhibitor, might influence signaling pathways activated by Vmn1r173. If Src kinase is part of the cascade downstream of Vmn1r173, PP2 could inhibit this kinase, potentially reducing the cellular responses mediated by the receptor. | ||||||
2-Amino-5-methylpyridine | 1603-41-4 | sc-209050 | 5 g | $140.00 | ||
2-Aminoethoxydiphenyl borate (2-APB) is an IP3 receptor inhibitor. If Vmn1r173 signals through pathways involving IP3 and Ca2+ release, 2-APB could inhibit the IP3 receptor, affecting the downstream cellular responses mediated by Vmn1r173. | ||||||